GlassScriptPhysician profile
John R Dorris
NPI 1104807429
$68,124.37
in general payments reported to CMS, 2019-2025
14 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $35K · 2021: $599 · 2022: $190 · 2023: $1,820 · 2024: $171 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $614.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tracpatch Health, INC | $64,596.00 | 2019-2020 | |
| Shalby Advanced Technologies, INC. | $1,966.53 | 2022-2025 | Consensus Knee System, Cks - Vitalite, Consensus Knee System |
| Stryker Corporation | $547.98 | 2019-2022 | |
| Osteoremedies, LLC | $417.26 | 2019-2021 | |
| Encore Medical, LP | $166.79 | 2019-2022 | |
| Arthrosurface Incorporated | $82.46 | 2020 | |
| Fx Shoulder Solutions, INC | $79.27 | 2024 | |
| Ossio INC | $75.61 | 2023 | |
| Smith+Nephew, INC. | $54.38 | 2020 | |
| Pacira Therapeutics, INC. | $52.91 | 2019-2021 | |
| Bioventus LLC | $31.09 | 2019 | |
| Djo, LLC | $23.22 | 2025 | Cmf |
| Depuy Synthes Sales INC. | $18.21 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,459,208.88 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dorris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.